<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05051540</url>
  </required_header>
  <id_info>
    <org_study_id>20210807</org_study_id>
    <nct_id>NCT05051540</nct_id>
  </id_info>
  <brief_title>The Effect of Inelastic Compression System on Quality of Life in People With Chronic Venous Insufficiency</brief_title>
  <official_title>The Effect of Inelastic Compression System on Quality of Life in People With Chronic Venous Insufficiency</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this protocol is to measure the effect of the use of an inelastic compression&#xD;
      system (ICS) on quality of life (QOL) in patients with chronic venous insufficiency (CVI) who&#xD;
      have demonstrated limited or no compliance with prescribed compression stockings or bandage&#xD;
      wraps.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the Quality of Life as measured by CIVIQ-20</measure>
    <time_frame>Baseline to 6 weeks</time_frame>
    <description>Chronic Venous Disease Quality of Life Questionnaire (CIVIQ-20) consists of 20 multiple choice questions subdivided into four categories: psychology, pain, physical repercussions and social repercussions. The questionnaire has a total score ranging from 0 to 100 the lower score indicating greater quality of life.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Chronic Venous Insufficiency</condition>
  <arm_group>
    <arm_group_label>Inelastic Compression System Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will receive the inelastic compression wrap for daily use on their legs for 6 consecutive weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sigvaris Compreflex Inelastic Compression Wrap</intervention_name>
    <description>Compreflex compression system using wraps to apply compression of 30-40 mmHg.</description>
    <arm_group_label>Inelastic Compression System Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject is age 18 or older, able and willing to provide consent and agrees to comply&#xD;
             with the study procedures&#xD;
&#xD;
          -  Subject must have chronic venous insufficiency of stages C3, C4, or C5 according to&#xD;
             the Clinical-Etiological-Anatomical-Pathophysiological (CEAP) classification system&#xD;
&#xD;
          -  Not compliant with their currently prescribed compression system&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active malignancy other than non-melanoma skin cancer&#xD;
&#xD;
          -  Study ulcer suspicious for cancer&#xD;
&#xD;
          -  Subjects who are pregnant and/or breastfeeding&#xD;
&#xD;
          -  In the opinion of the PI the subject cannot comply with study procedures&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hadar Lev-Tov, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maria Muniz</last_name>
    <phone>305-689-2646</phone>
    <email>mmuniz@med.miami.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Muniz</last_name>
      <phone>305-689-2646</phone>
      <email>mmuniz@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Hadar Lev-Tov, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>September 10, 2021</study_first_submitted>
  <study_first_submitted_qc>September 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 21, 2021</study_first_posted>
  <last_update_submitted>November 8, 2021</last_update_submitted>
  <last_update_submitted_qc>November 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Hadar Lev-Tov</investigator_full_name>
    <investigator_title>Assistant Professor of Clinical</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Venous Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

